V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007411 | 300004086 | 1.86 | 81.6 | Curative (C) | 2016-03-24 | 2016-05-15 | CARBOPLATIN + RT | null | Y | 300008757 | CETUXIMAB + RT |
| 300007412 | 300004087 | 1.63 | 70 | Palliative (P) | 2015-08-17 | 2015-09-15 | CETUXIMAB | 2 | N | 300008772 | IRINOTECAN + MDG |
| 300007413 | 300004088 | 1.65 | 59.15 | Curative (C) | 2018-02-02 | 2018-02-02 | Carboplatin AUC 6 - 10 | N | null | 300008788 | CISPLATIN + DOCETAXEL |
| 300007414 | 300004090 | 1.52 | 61.6 | Curative (C) | 2016-06-29 | 2017-03-22 | Eribulin | N | N | 300008807 | PACLITAXEL |
| 300007415 | 300004092 | 1.73 | null | Curative (C) | 2019-02-07 | 2019-02-10 | Bortezomib + CYCLOPHOSPHAMIDE | N | null | 300008826 | TRIAL |
| 300007416 | 300004096 | 1.73 | 83 | Palliative (P) | 2015-05-07 | 2015-05-14 | NIVOLUMAB | N | N | 300008892 | CISPLATIN |
| 300007418 | 300004101 | 1.55 | null | Palliative (P) | 2017-12-09 | 2018-10-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300008921 | CAPECITABINE + CARBOPLATIN |
| 300007419 | 300006680 | 1.68 | 65.7 | Curative (C) | 2015-05-23 | 2015-05-24 | CARBOPLATIN + FLUOROURACIL | N | N | 300008924 | CAPE + CARBOPLATIN + CETUXIMAB |
| 300007420 | 300004103 | 1.49 | 74.6 | Palliative (P) | null | 2017-09-04 | Carboplatin AUC 2 - 5 | 02 | N | 300008935 | OXALIPLATIN + MDG |
| 300007421 | 300004107 | 1.85 | 68.8 | Palliative (P) | 2018-07-10 | 2018-07-25 | Oxaliplatin + Modified de Gramont | 02 | N | 300008979 | SUNITINIB |
| 300007422 | 300004108 | 1.58 | 69.5 | Curative (C) | 2014-03-22 | 2014-03-22 | Cetuximab + Radiotherapy Maint | N | Y | 300009006 | CETUXIMAB + RT |
| 300007423 | 300004108 | 1.8 | 68 | Palliative (P) | 2017-09-21 | 2017-12-02 | Gemcitabine + Capecitabine | 2 | N | 300009006 | FEC + DOCETAXEL |
| 300007424 | 300004109 | 1.54 | 69.4 | Palliative (P) | 2018-03-07 | 2018-03-23 | Capecitabine | 02 | N | 300009014 | BEVACIZUMAB |
| 300007425 | 300004111 | null | null | Palliative (P) | 2017-11-25 | 2017-11-30 | CARBOPLATIN + RT | null | Y | 300009033 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 300007426 | 300004115 | 2 | null | null | 2013-04-18 | 2013-09-13 | KESTREL Trial | N | null | 300009057 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 300007427 | 300004117 | null | 74.7 | Palliative (P) | 2015-04-29 | 2015-05-16 | Capecitabine + Oxaliplatin 21day | N | N | 300009058 | TRIAL |
| 300007428 | 300004124 | 1.56 | 66 | Palliative (P) | null | 2015-10-25 | BENDAMUSTINE | 02 | N | 300009123 | BEVACIZUMAB |
| 300007429 | 300004129 | 1.73 | 78.6 | Palliative (P) | 2015-03-06 | 2015-03-07 | KESTREL Trial | 02 | null | 300009147 | CETUXIMAB + RT |
| 300007430 | 300004141 | 1.58 | 75 | Curative (C) | 2015-01-04 | 2015-02-18 | Carboplatin AUC 2 - 5 | 2 | N | 300009261 | CHOP R |
| 300007431 | 300004144 | 1.63 | null | null | 2014-01-01 | 2014-01-01 | Trial Unspecified | 02 | null | 300009289 | CETUXIMAB |
| 300007432 | 300004146 | 1.58 | null | Palliative (P) | 2016-06-08 | 2016-08-10 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | 300009291 | CISPLATIN + FLUOROURACIL |
| 300007433 | 300004149 | 1.55 | null | Palliative (P) | 2017-10-03 | 2017-10-11 | Carboplatin AUC 6 - 10 | N | N | 300009313 | CISPLATIN |
| 300007434 | 300004153 | 1.67 | 88.35 | Palliative (P) | 2017-05-20 | 2018-03-03 | Cetuximab 7 day (Cycle 1) | 02 | N | 300009703 | CETUXIMAB + RT |
| 300007435 | 300004154 | 1.63 | 63.8 | Palliative (P) | 2018-03-12 | 2018-03-28 | BENDAMUSTINE | 02 | N | 300010019 | GEMCARBO |
| 300007436 | 300004162 | 1.67 | null | Adjuvant (A) | 2014-01-29 | 2014-03-11 | Cisplatin 7 day | 02 | null | 300013793 | CISPLATIN + FLUOROURACIL |
| 300007437 | 300004163 | 1.57 | 78.7 | Palliative (P) | 2013-09-30 | 2014-09-15 | Topotecan (intravenous) | N | N | 300013798 | CISPLATIN + FLUOROURACIL |
| 300007438 | 300004164 | null | 92.1 | null | 2014-08-29 | 2014-09-09 | CNS LGG | 02 | N | 300013803 | CISPLATIN + FLUOROURACIL + RT |
| 300007439 | 300004166 | 1.86 | 57.2 | Palliative (P) | 2016-10-31 | 2016-12-07 | Cisplatin 7 day | 02 | Y | 300013864 | CISPLATIN + FLUOROURACIL + RT |
| 300007440 | 300004167 | 1.75 | 77.6 | Palliative (P) | 2018-11-07 | 2018-11-29 | Oxaliplatin + Modified de Gramont | N | N | 300013869 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 300007441 | 300008088 | 1.85 | 102.2 | Palliative (P) | 2012-07-20 | 2014-01-21 | Capecitabine + Cisplatin | N | N | 300013941 | CETUXIMAB |
| 300007443 | 300004173 | 1.66 | 77.5 | Palliative (P) | 2015-07-20 | 2015-07-30 | Capecitabine | 02 | N | 300014006 | CARBOPLATIN + ETOPOSIDE |
| 300007444 | 300004175 | 1.8 | 61.7 | Curative (C) | 2017-01-20 | 2017-02-01 | KESTREL Trial | N | N | 300014043 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007445 | 300004176 | 1.71 | 55.6 | null | 2013-05-17 | 2013-05-17 | Cisplatin | N | Y | 300014044 | CETUXIMAB + RT |
| 300007446 | 300004180 | null | 69 | Palliative (P) | 2012-05-08 | 2018-01-24 | LUX TRIAL | 02 | N | 300014132 | CAPECITABINE |
| 300007447 | 300004181 | 1.81 | null | Curative (C) | 2016-06-27 | 2017-07-31 | Carboplatin AUC 2 - 5 | 2 | N | 300014146 | CAPECITABINE |
| 300007448 | 300004184 | 1.57 | 45.2 | Palliative (P) | null | 2017-08-09 | Cetuximab + Radiotherapy Maint | null | null | 300014230 | CETUXIMAB |
| 300007449 | 300004187 | 1.6 | 98 | Neo-adjuvant (N) | 2018-01-13 | 2018-01-29 | Cisplatin | 02 | N | 300014236 | CAPECITABINE |
| 300007450 | 300004187 | 1.61 | 55.4 | Palliative (P) | 2015-01-05 | 2015-01-13 | Brentuximab | 02 | N | 300014236 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007452 | 300004192 | 1.66 | 62.2 | Adjuvant (A) | null | 2016-06-07 | Oxaliplatin + Modified de Gramont | N | N | 300014343 | CAPECITABINE + CARBOPLATIN |
| 300007453 | 300004193 | 1.85 | 68.5 | Palliative (P) | 2014-01-26 | 2014-03-02 | ESPAC-4 TRIAL | 02 | null | 300014360 | TRIAL |
| 300007454 | 300004194 | 1.78 | 72.1 | Curative (C) | 2015-04-04 | 2017-03-15 | Topotecan (intravenous) | 02 | N | 300014360 | CAPECITABINE |
| 300007455 | 300004197 | null | 40 | null | 2017-12-24 | 2017-12-27 | CAPECITABINE + OXALIPLATIN | N | null | 300014390 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300007456 | 300004199 | 1.54 | 60.5 | Curative (C) | 2018-01-02 | 2018-03-17 | DE-ESCALATE TRIAL | 02 | null | 300014406 | CETUXIMAB |
| 300007457 | 300004201 | 1.78 | 87.4 | Palliative (P) | 2017-12-25 | 2018-02-19 | PEMBROLIZUMAB | 02 | N | 300014421 | OXALIPLATIN + MDG |
| 300007460 | 300004203 | 1.72 | 58.6 | null | 2015-02-20 | 2015-03-02 | Carboplatin AUC 2 - 5 | null | Y | 300014501 | CARBOPLATIN |
| 300007461 | 300004205 | 1.71 | 80 | Palliative (P) | 2013-11-18 | 2014-01-09 | CAV | 02 | N | 300014524 | OXALIPLATIN + MDG |
| 300007462 | 300004206 | 1.65 | 55.55 | Curative (C) | 2016-03-11 | 2016-03-26 | ESPAC-4 TRIAL | N | null | 300014526 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007463 | 300004208 | 1.65 | null | Palliative (P) | null | 2015-03-12 | ESPAC-4 TRIAL | Y | N | 300014577 | CAPECITABINE + OXALIPLATIN |
| 300007464 | 300006751 | 1.63 | 110 | Palliative (P) | null | 2013-11-20 | Trastuzumab Subcutaneous | N | N | 300014610 | CAPECITABINE |
| 300007465 | 300004213 | 1.73 | 93.4 | Palliative (P) | null | 2017-09-12 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300014618 | CARBOPLATIN |